Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Therapeutic area

Injury, poisoning and procedural complications – page 3

  • 286 clinical trials
  • 125 recruiting
  • 217 conditions
  • 25 countries

Conditions in this area

217 conditions with trials, the busiest first

Procedural pain29Subarachnoid haemorrhage16Chronic graft versus host disease13Craniocerebral injury10Graft versus host disease10Kidney transplant rejection10Short-bowel syndrome10Acute graft versus host disease9Hypoparathyroidism9Medical device site joint infection8Thermal burn8Post procedural complication7Hip fracture6Cardiac function disturbance postoperative5Retinopathy of prematurity5Transplant rejection5Complex regional pain syndrome4Postoperative analgesia4Radius fracture4Skin wound4Spinal cord injury4Acute graft versus host disease in intestine3Acute graft versus host disease in skin3Acute kidney injury3+193

Clinical trials in Injury, poisoning and procedural complications

286 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

286 clinical trials

Vasoplegia syndrome

Recruiting

Early Treatment with Argipressin (Arginine Vasopressin) in Adult Intensive Care Patients with Norepinephrine-Resistant Vasoplegic Shock

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Argipressin
  • Sponsor:Centre Hospitalier Universitaire De Dijon

Poisoning

Recruiting

Study on Reduction of Toxicant Levels in Blood through Combined Digestive Decontamination with Activated Charcoal and Intestinal Purge for Intubated Patients with Major Poisoning in Intensive Care

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Charcoal, Activated
  • Sponsor:Assistance Publique Hopitaux De Paris

Renal transplant+1

Recruiting

Study of Ravulizumab to Prevent Delayed Graft Function in Adult Patients After Kidney Transplant

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Ravulizumab
  • Sponsor:Alexion Pharmaceuticals Inc.

Toxic epidermal necrolysis

Recruiting

Treatment with Mesenchymal Stromal Cells for Adults with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS-TEN) Affecting More Than 10% of Body Surface

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Allogeneic Adipose-Derived Mesenchymal Stromal Cells, Ex-Vivo Expanded
  • Sponsor:Assistance Publique Hopitaux De Paris

Short-bowel syndrome

Recruiting

Study on How Apixaban and Teduglutide Affect Patients with Short Bowel Syndrome on Long-Term Parenteral Nutrition

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Apixaban
  • Sponsor:UZ Leuven

Craniocerebral injury

Recruiting

Study on Dopaminergic Pathway Disruption in Comatose Patients with Traumatic Brain Injury Using [18F]LBT-999

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · Healthy volunteers
  • Sponsor:Inserm

Renal transplant

Recruiting

Comparison of Tacrolimus alone versus Tacrolimus, Mycophenolate mofetil and Prednisone combination in elderly kidney transplant patients to reduce infections

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Prednisone
  • Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Atrial fibrillation+2

Recruiting

Study on Early vs. Late Restart of Anticoagulation with Edoxaban, Apixaban, and Warfarin for Patients with Chronic Subdural Hematoma and Atrial Fibrillation

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:HUS-Yhtymae

Subarachnoid haemorrhage+1

Recruiting

Study on the Effectiveness of Lidocaine Hydrochloride and Sodium Chloride for Treating Headaches in Patients with Spontaneous Brain Bleeding

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau

Weaning failure

Recruiting

Study on Faster Weaning from Ventilators in Critically Ill Patients Using Levosimendan and a Drug Combination

Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Biotin
  • Sponsor:Stichting Radboud University Medical Center

Subarachnoid haemorrhage

Recruiting

Study of cilostazol and nimodipine combination to improve outcomes in patients with aneurysmal subarachnoid hemorrhage

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:CILOSTAZOL
  • Sponsor:Groupe Hospitalier Universitaire Paris Psychiatrie Et Neuroscience

Thermal burn

Recruiting

Study of dexamethasone effectiveness in reducing complications and mortality in patients with severe burns

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Centre Hospitalier Universitaire De Nantes

Substances studied in this area

The therapies tested most often in Injury, poisoning and procedural complications trials.

Sodium Chloride44 clinical trialsParacetamol15 clinical trialsLidocaine Hydrochloride11 clinical trialsMycophenolate Mofetil8 clinical trialsOxygen7 clinical trialsRopivacaine Hydrochloride7 clinical trialsTacrolimus7 clinical trialsAmoxicillin6 clinical trialsPrednisone6 clinical trials
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.